Detection of melanomas in patients followed up with total cutaneous examinations, total cutaneous photography, and dermoscopy

Journal of the American Academy of Dermatology

Volumn 50, Issue 1, 2004, Pages 15-20

  Wang, Steven Q ^b   Kopf, Alfred W ^a   Koenig, Karen ^a   Polsky, David ^a   Nudel, Kira ^a   Bart, Robert S ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER RISK; CLINICAL PRACTICE; COHORT ANALYSIS; DYSPLASTIC NEVUS; EPILUMINESCENCE MICROSCOPY; FAMILY HISTORY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL PHOTOGRAPHY; MELANOMA; PRIORITY JOURNAL; RISK FACTOR; SKIN BIOPSY; SKIN TUMOR; TUMOR DIAGNOSIS;

EID: 0345742662     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0190-9622(03)02794-4     Document Type: Article

References (22)

1. Tucker MA, Halpern A, Holly EA, Hartge P, Elder DE, Sagebiel RW, et al. Clinically recognized dysplastic nevi: a central risk factor for cutaneous melanoma. JAMA 1997;277:1439-44.
2. Halpern AC, Guerry DT, Elder DE, Clark WH Jr, Synnestvedt M, Norman S, et al. Dysplastic nevi as risk markers of sporadic (non-familial) melanoma: a case-control study. Arch Dermatol 1991; 127:995-9.
3. Halpern AC, Guerry DT, Elder DE, Trock B, Synnestvedt M. A cohort study of melanoma in patients with dysplastic nevi. J Invest Dermatol 1993;100(Suppl):346-95.
4. Kang S, Barnhill RL, Mihm MC Jr, Sober AJ. Multiple primary cutaneous melanomas. Cancer 1992;70:1911-6.
5. Rigel DS, Rivers JK, Friedman RJ, Kopf AW. Risk gradient for malignant melanoma in individuals with dysplastic naevi. Lancet 1988;1:352-3.
6. Rigel DS, Rivers JK, Kopf AW, Friedman RJ, Vinokur AF, Heilman ER, et al. Dysplastic nevi: markers for increased risk for melanoma. Cancer 1989;63:386-9.
7. Holly EA, Kelly JW, Shpall SN, Chiu SH. Number of melanocytic nevi as a major risk factor for malignant melanoma. J Am Acad Dermatol 1987;17:459-68.
8. Kopf AW, Friedman RJ, Rigel DS. Atypical mole syndrome. J Am Acad Dermatol 1990;22:117-8.
9. Marghoob AA, Kopf AW, Rigel DS, Bart RS, Friedman RJ, Yadav S, et al. Risk of cutaneous malignant melanoma in patients with "classic" atypical-mole syndrome: a case-control study. Arch Dermatol 1994;130:993-8.
10. Rigel DS, Friedman RJ, Kopf AW, Weltman R, Prioleau PG, Safai B, et al. Importance of complete cutaneous examination for the detection of malignant melanoma. J Am Acad Dermatol 1986; 14:857-60.
11. Tiersten AD, Grin CM, Kopf AW, Gottlieb GJ, Bart RS, Rigel DS, et al. Prospective follow-up for malignant melanoma in patients with atypical-mole (dysplastic-nevus) syndrome. J Dermatol Surg Oncol 1991;17:44-8.
12. Slue W, Kopf AW, Rivers JK. Total-body photographs of dysplastic nevi. Arch Dermatol 1988;124:1239-43.
13. Steiner A, Pehamberger H, Wolff K. In vivo epiluminescence microscopy of pigmented skin lesions: II, diagnosis of small pigmented skin lesions and early detection of malignant melanoma. J Am Acad Dermatol 1987;17:584-91.
14. MacKie RM, Freudenberger T, Aitchison TC. Personal risk-factor chart for cutaneous melanoma. Lancet 1989;2:487-90.
15. Tucker MA, Fraser MC, Goldstein AM, Elder DE, Guerry Dt, Organic SM. Risk of melanoma and other cancers in melanomaprone families. J Invest Dermatol 1993;100(Suppl):350-5S.
16. Holman CD, Armstrong BK. Cutaneous malignant melanoma and indicators of total accumulated exposure to the sun: an analysis separating histogenetic types. J Natl Cancer Inst 1984; 73:75-82.
17. Marghoob AA, Slade J, Salopek TG, Kopf AW, Bart RS, Rigel DS. Basal cell and squamous cell carcinomas are important risk factors for cutaneous malignant melanoma: screening implications. Cancer 1995;75:707-14.
18. Lindelof B, Sigurgeirsson B, Wallberg P, Eklund G. Occurrence of other malignancies in 1973 patients with basal cell carcinoma. J Am Acad Dermatol 1991;25:245-8.
19. Green AC, O'Rourke MG. Cutaneous malignant melanoma in association with other skin cancers. J Natl Cancer Inst 1985;74:977-80.
20. Pehamberger H, Binder M, Steiner A, Wolff K. In vivo epiluminescence microscopy: improvement of early diagnosis of melanoma. J Invest Dermatol 1993;100(Suppl):356-625.
21. Nachbar F, Stolz W, Merkle T, Cognetta AB, Vogt T, Landthaler M, et al. The ABCD rule of dermatoscopy: high prospective value in the diagnosis of doubtful melanocytic skin lesions. J Am Acad Dermatol 1994;30:551-9.
22. MacKie RM, McHenry P, Hole D. Accelerated detection with prospective surveillance for cutaneous malignant melanoma in high-risk groups. Lancet 1993;341:1618-20.